Neuroscience Notes Main Page

Neurologist Trained in Neuropsychiatry to Lead Cognitive Neurology Program

A widely published physician trained in neurology, cognitive – behavioral neurology, and neuropsychiatry has joined the Capital Institute for Neurosciences to lead the Cognitive Neurology Program, which provides comprehensive services for patients with Alzheimer's Disease, memory loss and other cognitive disorders.

G. Peter Gliebus, MD, was the J. Rosenstone Behavioral Neurology and Neuropsychiatry fellow at the Northwestern University Feinberg School of Medicine in Chicago. He completed his Neurology Residence at Drexel University College of Medicine and Hahnemann University Hospital.

Most recently, Dr. Gliebus worked as a practicing neurologist at Cumberland Valley Neurosurgical Consultants.

Dr. Gliebus said a cognitive neurology program that is part of a neuroscience institute provides many advantages to patients, such as the ability to offer a range of neurologic services, including state-of-the art brain imaging and vascular interventions.

“Someone may come in with a diagnosis of Alzheimer’s Disease, but in fact the person may be having small seizures or strokes, or a metabolic impairment. We see this happen,” Dr. Gliebus said. “In a neuroscience institute we have access to the latest technology, testing and interventions all in the same place.”

Dr. Gliebus said the Cognitive Neurology Program evaluates and treats all patients with memory complaints, including younger people.

“Some people have self-perceived memory loss, and we help them sort it out,” he said. “Sometimes people set high standards for themselves while in fact they are merely experiencing normal aging.”

The program also provides support and education for families and caregivers of patients with dementia and Alzheimer’s Disease.

“Having the caregiver burn out does not help anyone,” Dr. Gliebus said. “When someone is losing his or her memory or experiencing personality change, it can be difficult for those around them. We need to provide a lot of education to these families.”

Dr. Gliebus said no cure currently exists for Alzheimer’s Disease, although physicians can help patients in many ways, such as providing medications which have been shown to prolong functional independence, address anxiety, depression, or sleep-related issues that may accompany the disease.

“Our interventions can help people prolong their years of independence,” he said.

Additionally, Dr. Gliebus is establishing a center to evaluate people who develop cognitive impairment over weeks or months, called rapidly progressive cognitive impairment. This impairment requires different approaches and diagnostic capabilities. The disease spectrum ranges from rare infections to autoimmune diseases, or conditions such as Creutzfeld-Jacob disease.

Dr. Erol Veznedaroglu, director of the Capital Institute for Neurosciences, said Dr. Gliebus brings compassion and experience, as well as a research background, to the Cognitive Neurology Program.

Dr. Gliebus’ published work includes studies on neurofibrillary tangles in Alzheimer’s Disease, beta-Amyloid distribution in Alzheimer’s Disease, and the effect of certain medications on memory.

“As our population ages, it is even more important that we have dedicated physicians such as Dr. Gliebus on the frontlines of both patient care and research,” Dr. Veznedaroglu said. “We must continue to work toward cures as well as do everything possible today for patients and their families.”

To schedule an appointment with Dr. Gliebus, call 609-537-7300.

Back to top